Evidence map›Paper›PMID 25714006›Full record

ArticleCell cycle (Georgetown, Tex.)2015

Identification of rictor as a novel substrate of Polo-like kinase 1.

Tian Shao, Xiaoqi Liu

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Tian Shaoa Department of Biochemistry ; Purdue University ; West Lafayette , IN USA.
Xiaoqi Liu
Center for Cancer Research · USPurdue University West Lafayette · US

Funding

Transgenic Mouse Core Facility Shared Resource (TMCF-SR)P30CA023168 · NCI · PURDUE UNIVERSITY WEST LAFAYETTE · PI John Tesmer · 1985 to 2026
$43.4M
Plk1 in Chemo-resistance of CancerR01CA157429 · NCI · UNIVERSITY OF KENTUCKY · PI XIAOQI LIU · 2011 to 2026
$3.5M
NCI NIH HHS P30 CA023168NCI NIH HHS R01CA157429
6 · The paper itself

Abstract

Plk1 has been essentially described as a critical regulator of many mitotic events. However, increasing evidence supports the notion that its molecular functions are not restricted to the cell cycle. In particular, recent reports suggest the existence of a molecular and functional link between Plk1 and the mammalian target of rapamycin (mTOR) pathway, which controls cell growth and proliferation via the raptor-mTOR (TORC1) and rictor-mTOR (TORC2) protein complexes. Herein, we have identified rapamycin-insensitive companion of mTOR (Rictor), a core component of mTORC2, as a new Plk1 substrate and have shown that Plk1 phosphorylates Rictor at Ser1162 in vitro and in vivo. Surprisingly, cells expressing the unphosphorylatable mutant (S1162A) of Rictor did not show any effect on well characterized canonical PI3K-mTOR pathway. However, we found that cells expressing the unphosphorylatable form of Rictor have an elevated level of mSin1 isoform (mSin1.5). Considering that mSin1.5-containing mTORC2 was reported to associate with stress signaling, we propose that phosphorylation of Rictor at Ser1162 by Plk1 might be involved in a novel signaling pathway by regulating the mSin1.5-defined mTORC2.

Indexed as

Amino Acid SequenceCarrier ProteinsCell Cycle ProteinsCell Line, TumorHEK293 CellsHumansMechanistic Target of Rapamycin Complex 1Molecular Sequence DataMultiprotein ComplexesPhosphatidylinositol 3-KinasesPhosphorylationPhosphoserinePolo-Like Kinase 1Protein BindingProtein IsoformsProtein Serine-Threonine KinasesCarrier ProteinsCell Cycle ProteinsMechanistic Target of Rapamycin Complex 1Multiprotein ComplexesPhosphatidylinositol 3-KinasesPhosphoserinePolo-Like Kinase 1Protein IsoformsProtein Serine-Threonine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-aktRapamycin-Insensitive Companion of mTOR ProteinRICTOR protein, humanTOR Serine-Threonine Kinases4E-BP1, eIF4E-binding protein 1aa, amino acidscell cycleGST, glutathione S-transferaseIB, immunoblotting.IP, immunoprecipitationmSin1mSin1, mammalian stress-activated map kinase-interacting protein 1 (mSin1)mTORCmTORC1, mTOR complex 1mTORC2, mTOR complex 2mTOR, mammalian target of rapamycinPDK1, 3-phophoinositide-dependent protein kinase 1 (PDK1)phosphorylationPlk1Plk1, polo-like kinase 1Raptor, regulatory-associated protein of mTORRictorRictor, rapamycin-insensitive companion of mTORS6K, S6 KinaseWT, wild type

Identifiers

PMID25714006
PMCPMC4615041
OpenAlexW1556826884

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.